Analyzing the Epidemiologic Mortality Trends Among Patients with Comorbid Alzheimer’s Disease and Cerebrovascular Disease in the United States from 1999 to 2024: Insights from the CDC WONDER Database
Srinath Ramanan1, Anosh John2, Faraz Azhar2, Daniel Isaza Pierotti3, Salman Assad4, Ayman Alboudi5, Muhammad Adeel Saleemi3
1Department of Neurology, UConn Health, 2Allama Iqbal Medical College, 3Department of Neurology and Neurosurgery, University of South Alabama, 4Cooper Neurologic Institute, Cooper University Hospital, 5Department of Neurology, Wayne State University, Detroit Medical Center
Objective:

This study aims to investigate the mortality trends and disparities among patients with comorbid Alzheimer’s disease and cerebrovascular disease.

Background:

Alzheimer’s disease (AD) is associated with increased risk of cerebrovascular disease through shared vascular and neurodegenerative pathways. Given the limited existing data, this study aims to characterize contemporary trends in coexisting AD and cerebrovascular disease-related mortality among United States (US) adults (≥45 years old).

Design/Methods:

The Centers for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database was used to acquire the mortality data. The age-adjusted mortality rates (AAMR) per 100,000 population were extracted. Cerebrovascular disease was identified using ICD-10 codes I60-I69. AD was identified using ICD-10 code G30. Those deaths were included in the analysis where both AD and cerebrovascular disease were either the underlying or contributing cause. Trends were analyzed by year, sex, and census region. Joinpoint regression was used to calculate the annual percent change (APC) in AAMR with 95% confidence intervals. Weighted average APCs were calculated and reported as AAPCs with 95% CIs to summarize mortality trends over the study period.

Results:

From 1999 to 2024, a total of 209,934 deaths were associated with coexisting AD and cerebrovascular disease, with an overall average AAMR of 6.84 per 100,000. The AAMR declined from 8.26 in 1999 to 6.14 in 2024 (AAPC: –1.27; p < 0.001). Women had a higher average AAMR than men (7.33 versus 5.93), though both showed significant declines (males: AAPC –1.36; p < 0.001; females: AAPC –1.08; p < 0.001). By region, the West had the highest average AAMR (8.02), followed by the South (7.41), the Midwest (7.12), and the Northeast (4.33).

Conclusions:

Mortality from coexisting cerebrovascular disease and AD decreased nationwide, yet continues to show marked demographic and regional disparities, underscoring the need for targeted prevention and intervention strategies.

10.1212/WNL.0000000000215883
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.